Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool.


Journal

Cellular & molecular immunology
ISSN: 2042-0226
Titre abrégé: Cell Mol Immunol
Pays: China
ID NLM: 101242872

Informations de publication

Date de publication:
02 2021
Historique:
received: 21 04 2020
accepted: 14 11 2020
pubmed: 8 1 2021
medline: 28 12 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

Signaling via interleukin-2 receptor (IL-2R) is a requisite for regulatory T (Treg) cell identity and function. However, it is not completely understood to what degree IL-2R signaling is required for Treg cell homeostasis, lineage stability and function in both resting and inflammatory conditions. Here, we characterized a spontaneous mutant mouse strain endowed with a hypomorphic Tyr129His variant of CD25, the α-chain of IL-2R, which resulted in diminished receptor expression and reduced IL-2R signaling. Under noninflammatory conditions, Cd25

Identifiants

pubmed: 33408345
doi: 10.1038/s41423-020-00599-z
pii: 10.1038/s41423-020-00599-z
pmc: PMC8027001
doi:

Substances chimiques

Forkhead Transcription Factors 0
Il2ra protein, mouse 0
Interleukin-2 0
Interleukin-2 Receptor alpha Subunit 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

398-414

Références

Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330–336 (2003).
pubmed: 12612578
Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1062 (2003).
Bayer, A. L., Yu, A. & Malek, T. R. Function of the IL-2R for Thymic and Peripheral CD4+CD25+ Foxp3+ T regulatory cells. J. Immunol. 178, 4062–4071 (2007).
pubmed: 17371960
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142–1151 (2005).
pubmed: 16227984
Bayer, A. L., Yu, A., Adeegbe, D. & Malek, T. R. Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period. J. Exp. Med. 201, 769–777 (2005).
pubmed: 15753210 pmcid: 2212835
Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723–735 (2005).
pubmed: 15753206 pmcid: 2212841
Almeida, A. R. M., Legrand, N., Papiernik, M. & Freitas, A. A. Homeostasis of peripheral CD4+ T Cells: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4 + T cell numbers. J. Immunol. 169, 4850–4860 (2002).
pubmed: 12391195
Furtado, G. C., de Lafaille, M. A. C., Kutchukhidze, N. & Lafaille, J. J. Interleukin 2 signaling is required for CD4+ regulatory T cell function. J. Exp. Med. 196, 851–857 (2002).
pubmed: 12235217 pmcid: 2194060
De la Rosa, M., Rutz, S., Dorninger, H. & Scheffold, A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2480–2488 (2004).
pubmed: 15307180
Thornton, A. M., Donovan, E. E., Piccirillo, C. A. & Shevach, E. M. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+ CD25+ T cell suppressor function. J. Immunol. 172, 6519–6523 (2004).
pubmed: 15153463
Chinen, T. et al. An essential role for the IL-2 receptor in Treg cell function. Nat. Immunol. 17, 1322–1333 (2016).
pubmed: 27595233 pmcid: 5071159
Willerford, D. M. et al. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521–530 (1995).
pubmed: 7584142
Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253–261 (1993).
pubmed: 8402910
Suzuki, H. et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268, 1472–1476 (1995).
pubmed: 7770771
Burchill, M. A., Yang, J., Vogtenhuber, C., Blazar, B. R. & Farrar, M. A. IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280–290 (2007).
pubmed: 17182565
Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667–1671 (2010).
pubmed: 20929851 pmcid: 4262151
Murakami, M., Sakamoto, A., Bender, J., Kappler, J. & Marrack, P. CD25+CD4+T cells contribute to the control of memory CD8+T cells. Proc. Natl Acad. Sci. USA 99, 8832–8837 (2002).
pubmed: 12084927 pmcid: 124384
Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D. & Sprent, J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311, 1924–1927 (2006).
pubmed: 16484453
D’Cruz, L. M. & Klein, L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6, 1152–1159 (2005).
pubmed: 16227983
Boring, L. et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Investig. 100, 2552–2561 (1997).
pubmed: 9366570 pmcid: 508456
Kuziel, W. A. et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl Acad. Sci. USA 94, 12053–12058 (1997).
pubmed: 9342361 pmcid: 23699
Wang, Y. et al. Th2 lymphoproliferative disorder of Lat Y136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3 + regulatory T cells. J. Immunol. 180, 1565–1575 (2008).
pubmed: 18209052
Bleich, A. et al. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm. Genome 15, 865–871 (2004).
pubmed: 15672590
Garg, G. et al. Blimp1 prevents methylation of Foxp3 and loss of regulatory T cell identity at sites of inflammation. Cell Rep. 26, 1854–1868 (2019).
pubmed: 30759395 pmcid: 6389594
Hemmers, S. et al. IL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus. J. Exp. Med. 216, 2466–2478 (2019).
pubmed: 31434685 pmcid: 6829602
Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genom. 19, 447 (2018).
Stauber, D. J., Debler, E. W., Horton, P. A., Smith, K. A. & Wilson, I. A. Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc. Natl Acad. Sci. USA 103, 2788–2793 (2006).
pubmed: 16477002 pmcid: 1413841
Höfer, T., Krichevsky, O. & Altan-Bonnet, G. Competition for IL-2 between regulatory and effector T cells to chisel immune responses. Front. Immunol. 3, 1–9 (2012).
Pandiyan, P., Zheng, L., Ishihara, S., Reed, J. & Lenardo, M. J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353–1362 (2007).
pubmed: 17982458
Sharma, R. et al. A regulatory T cell-dependent novel function of CD25 (IL-2Rα) controlling memory CD8+ T cell homeostasis. J. Immunol. 178, 1251–1255 (2007).
pubmed: 17237369
Smigiel, K. S. et al. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J. Exp. Med. 211, 121–136 (2014).
pubmed: 24378538 pmcid: 3892972
Campbell, D. J. & Koch, M. A. Phenotypical and functional specialization of FOXP3+regulatory T cells. Nat. Rev. Immunol. 11, 119–130 (2011).
pubmed: 21267013 pmcid: 3289970
Miragaia, R. J. et al. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. Immunity 50, 493–504 (2019).
pubmed: 30737144 pmcid: 6382439
Xu, H. et al. MS4a4B, a CD20 homologue in T cells, inhibits T cell propagation by modulation of cell cycle. PLoS ONE 5, 1–12 (2010).
Vasanthakumar, A. et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 16, 276–285 (2015).
pubmed: 25599561
Vasanthakumar, A. et al. The TNF receptor superfamily-NF-κB axis is critical to maintain effector regulatory T cells in lymphoid and non-lymphoid tissues. Cell Rep. 20, 2906–2920 (2017).
pubmed: 28889989
Panduro, M., Benoist, C. & Mathis, D. Tissue Tregs. Annu. Rev. Immunol. 34, 609–633 (2016).
pubmed: 27168246 pmcid: 4942112
Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize T reg-mediated immune homeostasis. Nature 498, 506–510 (2013).
pubmed: 23728300 pmcid: 3710737
Xing, S. et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J. Exp. Med. 216, 847–866 (2019).
pubmed: 30837262 pmcid: 6446865
Beyer, M. et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat. Immunol. 12, 898–907 (2011).
pubmed: 21841785 pmcid: 3669688
Pabbisetty, S. K. et al. Peripheral tolerance can be modified by altering KLF2-regulated Treg migration. Proc. Natl Acad. Sci. USA 113, E4662–E4670 (2016).
pubmed: 27462110 pmcid: 4987800
Wakabayashi, Y. et al. Bcl11b is required for differentiation and survival of αβ T lymphocytes. Nat. Immunol. 4, 533–539 (2003).
pubmed: 12717433
Pierson, W. et al. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells. Nat. Immunol. 14, 959–965 (2013).
pubmed: 23852275 pmcid: 4128388
Yu, A., Zhu, L., Altman, N. H. & Malek, T. R. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 30, 204–217 (2009).
pubmed: 19185518 pmcid: 2962446
Zemmour, D. et al. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat. Immunol. 19, 291–301 (2018).
pubmed: 29434354 pmcid: 6069633
Hadis, U. et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 34, 237–246 (2011).
pubmed: 21333554
Mottet, C., Uhlig, H. H. & Powrie, F. Cutting edge: cure of colitis by CD4+ CD25+ regulatory T cells. J. Immunol. 170, 3939–3943 (2003).
pubmed: 12682220
Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190–200 (2001).
pubmed: 11722634
Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, 169–178 (2007).
Toomer, K. H. et al. Essential and non-overlapping IL-2Rα-dependent processes for thymic development and peripheral homeostasis of regulatory T cells. Nat. Commun. 10, 1037 (2019).
pubmed: 30833563 pmcid: 6399264
Vignoli, M. et al. CD25 deficiency: a new conformational mutation prevents the receptor expression on cell surface. Clin. Immunol. 201, 15–19 (2019).
pubmed: 30742970
Goudy, K. et al. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin. Immunol. 146, 248–261 (2013).
pubmed: 23416241 pmcid: 3594590
Caudy, A. A., Reddy, S. T., Chatila, T., Atkinson, J. P. & Verbsky, J. W. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 119, 482–487 (2007).
pubmed: 17196245
Sharfe, N., Dadi, H. K., Shahar, M. & Roifman, C. M. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc. Natl Acad. Sci. USA 94, 3168–3171 (1997).
pubmed: 9096364 pmcid: 20340
Busse, D. et al. Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proc. Natl Acad. Sci. USA 107, 3058–3063 (2010).
pubmed: 20133667 pmcid: 2840293
Barthlott, T. et al. CD25+CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int. Immunol. 17, 279–288 (2005).
pubmed: 15684039
Miyao, T. et al. Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T Cells. Immunity 36, 262–275 (2012).
pubmed: 22326580
Sakaguchi, S., Vignali, D. A. A., Rudensky, A. Y., Niec, R. E. & Waldmann, H. The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 13, 461–467 (2013).
pubmed: 23681097
Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000–1007 (2009).
pubmed: 19633673 pmcid: 2729804
Sawant, D. V. & Vignali, D. A. A. Once a Treg, always a Treg? Immunol. Rev. 259, 173–191 (2014).
pubmed: 24712466 pmcid: 4008876
Feng, Y. et al. Control of the inheritance of regulatory T cell identity by a cis element in the foxp3 locus. Cell 158, 749–763 (2014).
pubmed: 25126783 pmcid: 4151558
Malek, T. R., Yu, A., Vincek, V., Scibelli, P. & Kong, L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice: implications for the nonredundant function of IL-2. Immunity 17, 167–178 (2002).
pubmed: 12196288
Bayer, A. L., Lee, J. Y., de la Barrera, A., Surh, C. D. & Malek, T. R. A function for IL-7R for CD4+ CD25+ Foxp3+ T regulatory cells. J. Immunol. 181, 225–234 (2008).
pubmed: 18566388
Lio, C. W. J. & Hsieh, C. S. A two-step process for thymic regulatory T cell development. Immunity 28, 100–111 (2008).
pubmed: 18199417 pmcid: 2248212
Vang, K. B. et al. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+ Foxp3+ regulatory T cell development. J. Immunol. 181, 3285–3290 (2008).
pubmed: 18714000
DiSpirito, J. R. et al. Molecular diversification of regulatory T cells in nonlymphoid tissues. Sci. Immunol. 3, eaat5861 (2018).
pubmed: 30217811 pmcid: 6219455
Wang, Z. et al. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+CD25- T cells to CD4+ Tregs. J. Clin. Investig. 116, 2434–2441 (2006).
pubmed: 16906223 pmcid: 1533873
Nishibori, T., Tanabe, Y., Su, L. & David, M. Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199, 25–34 (2004).
pubmed: 14699080 pmcid: 1193645
Chang, J. H., Kim, Y. J., Han, S. H. & Kang, C. Y. IFN-γ-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis. Eur. J. Immunol. 39, 1241–1251 (2009).
pubmed: 19337996
Chorro, L. et al. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat. Commun. 9, 5368 (2018).
pubmed: 30560927 pmcid: 6299086
Li, P. et al. STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: functional dissection of the Il2ra gene locus. Proc. Natl Acad. Sci. USA 114, 12111–12119 (2017).
pubmed: 29078395 pmcid: 5699083
Simeonov, D. R. et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature 549, 111–115 (2017).
pubmed: 28854172 pmcid: 5675716

Auteurs

Marc Permanyer (M)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Berislav Bošnjak (B)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Silke Glage (S)

Institute for Laboratory Animal Science, Hannover Medical School, Hannover, Germany.

Michaela Friedrichsen (M)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Stefan Floess (S)

Department Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Jochen Huehn (J)

Department Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, 30625, Hannover, Germany.

Gwendolyn E Patzer (GE)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Ivan Odak (I)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Nadine Eckert (N)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Razieh Zargari (R)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Laura Ospina-Quintero (L)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Hristo Georgiev (H)

Institute of Immunology, Hannover Medical School, Hannover, Germany.

Reinhold Förster (R)

Institute of Immunology, Hannover Medical School, Hannover, Germany. foerster.reinhold@mh-hannover.de.
Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, 30625, Hannover, Germany. foerster.reinhold@mh-hannover.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH